The Rapid Test product category comprises a series of point-of-care diagnostic assays designed for fast and reliable pathogen detection within 12–15 minutes. This category includes three major segments: Respiratory Infections, Tropical Diseases, and Monkeypox.
All tests are based on Colloidal Gold Chromatographic Immunoassay, a widely adopted lateral flow methodology that provides straightforward operation, clear visual interpretation, and stable analytical performance. These rapid assays support timely screening and early diagnostic assessment across a broad range of clinical and field-based applications.
Key Sub-Categories
| Sub-Category | Focus | Core Benefit |
| Respiratory Infections | Influenza (A/B), COVID-19, RSV, and other common respiratory pathogens. | Facilitate immediate isolation and treatment protocols, especially crucial during seasonal outbreaks. |
| Tropical Diseases | Malaria, Dengue, Zika, and other diseases prevalent in endemic regions. | Enable rapid field diagnosis and screening to control disease spread and initiate life-saving interventions. |
| Monkeypox | Specific detection assays for the Monkeypox virus. | Support timely surveillance and contact tracing efforts during novel disease emergencies. |
